BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8481255)

  • 21. Clinical validation of St. Thomas' Hospital cardioplegic solution No. 2 (Plegisol).
    Chambers DJ; Sakai A; Braimbridge MV; Kosker S; Manzanera G; Kind PR; Jupp RA; Smith LD; Slavin B
    Eur J Cardiothorac Surg; 1989; 3(4):346-52. PubMed ID: 2624805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of cardioplegic solutions on coronary artery and myocardium--comparison of the glucose-insulin-potassium solution and the St. Thomas' Hospital cardioplegic solution].
    Watanabe H; Yokosawa T; Eguchi S; Imai S
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Oct; 37(10):2142-9. PubMed ID: 2685132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of oxygenation and consequent pH changes on the efficacy of St. Thomas' Hospital cardioplegic solution.
    von Oppell UO; King LM; Du Toit EF; Owen P; Reichart B; Opie LH
    J Thorac Cardiovasc Surg; 1991 Sep; 102(3):396-404. PubMed ID: 1908927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial protection during prolonged ischaemic cardiac arrest: experimental evaluation of three crystalloid cardioplegic solutions.
    Chong YS; Cottier DS; Gavin JB
    J Cardiovasc Surg (Torino); 1994 Feb; 35(1):35-44. PubMed ID: 8120076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of calcium concentration, lactobionate content, and sodium/ potassium ratio of preservation solutions on resting left ventricular pressure and postreperfusion function of rabbit heterotopic heart transplants.
    Termignon JL; Pradier F; Petit A; Journois D; Weiss M; Mazmanian M
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1126-35. PubMed ID: 8719460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of two different crystalloid cardioplegic solutions on cultured human endothelial cells.
    Solberg S; Larsen T; Lindal S; Prydz P; Jørgensen L; Sørlie D
    J Cardiovasc Surg (Torino); 1989; 30(4):669-74. PubMed ID: 2506190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nifedipine as an adjunct to St. Thomas' Hospital cardioplegia. A double-blind, placebo-controlled, randomized clinical trial.
    Flameng W; De Meyere R; Daenen W; Sergeant P; Ngalikpima V; Geboers J; Suy R; Stalpaert G
    J Thorac Cardiovasc Surg; 1986 May; 91(5):723-31. PubMed ID: 3517508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular kinetics of the activator calcium of rat heart after ischemic arrest and cardioplegia: quantitative comparison of right and left ventricles.
    Juggi JS; Mesaeli N; Yousof AM
    Can J Cardiol; 1992 May; 8(4):387-95. PubMed ID: 1377592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European versus North American cardioplegia: comparison of Bretschneider's and Roe's cardioplegic solutions in a canine model of cardiopulmonary bypass.
    Wilson GJ; Axford-Gatley RA; Bush BG; Romaschin AD; Mickle DA
    Thorac Cardiovasc Surg; 1990 Feb; 38(1):10-4. PubMed ID: 2106734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The temperature dependency of the protective properties of the St. Thomas' Hospital cardioplegic solution, the University of Wisconsin solution, and Bretschneider buffered solution].
    Kumada Y; Yamamoto F; Ishikawa T; Kagisaki K; Shimada Y; Ohashi T; Yamamoto H; Hirose H
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Dec; 45(12):1954-60. PubMed ID: 9455106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of UW solution and St. Thomas' solution in the rat: importance of potassium concentration.
    Rosenfeldt FL; Conyers RA; Jablonski P; Langley L; Richards SM; Self G; Marshall V
    Ann Thorac Surg; 1996 Feb; 61(2):576-84. PubMed ID: 8572770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effects of glucose and insulin upon functional recovery in the rat heart preserved by continuous perfusion with St. Thomas' Hospital cardioplegic solution].
    Shimada Y; Yamamoto F; Yamamoto H; Kumada Y; Kagisaki K; Ishikawa T; Oka T; Kawashima Y
    Nihon Kyobu Geka Gakkai Zasshi; 1995 Jul; 43(7):973-81. PubMed ID: 7561333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of immature myocardium by the addition of mannitol to crystalloid cardioplegic solution.
    Yang YJ
    J Formos Med Assoc; 1991 Jan; 90(1):24-30. PubMed ID: 1679105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness of University of Wisconsin solution on prolonged myocardial protection as assessed by phosphorus 31-nuclear magnetic resonance spectroscopy and functional recovery.
    Karck M; Vivi A; Tassini M; Schwalb H; Askenasy N; Navon G; Borman JB; Uretzky G
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1356-64. PubMed ID: 1434717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrograde versus antegrade delivery of cardioplegic solution in myocardial revascularization. A clinical trial in patients with three-vessel coronary artery disease who underwent myocardial revascularization with extensive use of the internal mammary artery.
    Noyez L; van Son JA; van der Werf T; Knape JT; Gimbrère J; van Asten WN; Lacquet LK; Flameng W
    J Thorac Cardiovasc Surg; 1993 May; 105(5):854-63. PubMed ID: 8487564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of oxygenation and/or SOD on addition to St. Thomas' Hospital cardioplegic solution].
    Kihana E
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Mar; 41(3):347-55. PubMed ID: 8478561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of the chronic hypoxic immature rat heart during global ischemia.
    Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A
    Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oxygenation of St. Thomas' Hospital cardioplegic solutions--effects of myocardial temperature and carbon dioxide].
    Mukaeyama Y; Yamamoto S
    Nihon Kyobu Geka Gakkai Zasshi; 1991 Feb; 39(2):133-43. PubMed ID: 2033329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left ventricular dysfunction after two hours of polarizing or depolarizing cardioplegic arrest in a porcine model.
    Aass T; Stangeland L; Moen CA; Solholm A; Dahle GO; Chambers DJ; Urban M; Nesheim K; Haaverstad R; Matre K; Grong K
    Perfusion; 2019 Jan; 34(1):67-75. PubMed ID: 30058944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardioplegia and vascular injury. Dissociation of the effects of ischemia from those of the cardioplegic solution.
    Saldanha C; Hearse DJ
    J Thorac Cardiovasc Surg; 1994 Aug; 108(2):279-90. PubMed ID: 8041176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.